Literature DB >> 6173171

Diagnosis of pericardial effusion by computed tomography.

B Y Wong, K R Lee, R I MacArthur.   

Abstract

We assessed the diagnostic utility of computed tomography (CT) in the detection of pericardial effusion by using a dog model in which the amount and type of pericardial fluid were controlled and by obtaining CT scans on patients with suspected pericardial effusion prior to pericardiocentesis. The experimental studies showed that CT was capable of detecting pericardial effusion composed of serous fluid or saline in amounts as small as 50 ml. However, the hemopericardium was radiographically isodense with the heart and difficult to detect by CT unless the epicardial fat pad was identified or intravenous contrast enhancement of the heart was used. CT clearly demonstrated the presence of pericardial effusion in all six patients studied prior to successful pericardiocentesis or pericardiectomy. We conclude that CT is a sensitive noninvasive method which can be used for the diagnosis of pericardial effusion.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6173171     DOI: 10.1378/chest.81.2.177

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  3 in total

1.  Incidence and Predictors of Pericardial Effusion After Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer.

Authors:  Matthew S Ning; Linglong Tang; Daniel R Gomez; Ting Xu; Yangkun Luo; Jinhai Huo; Elie Mouhayar; Zhongxing Liao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-05-22       Impact factor: 7.038

2.  Superior mediastinal obstruction with aortic dissection after aortic valve replacement. Diagnosis by computed tomography.

Authors:  D L Stone; M C Petch; G I Verney; A K Dixon
Journal:  Br Heart J       Date:  1984-05

3.  Illustrative cases in pericardial effusion misdetection: correlation of echocardiography and CT.

Authors:  D Yousem; T T Traill; P S Wheeler; E K Fishman
Journal:  Cardiovasc Intervent Radiol       Date:  1987       Impact factor: 2.740

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.